Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P33
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-8.77M | -140.1% |
| 2024 | $21.85M | +4713.7% |
| 2023 | $454000.00 | +102.1% |
| 2022 | $-22.10M | -8407.9% |
| 2021 | $266000.00 | -98.0% |
| 2020 | $13.61M | +192.5% |
| 2019 | $-14.72M | - |